IPIntJMedMicrobiolTropDis-8-3-255-2591
IPIntJMedMicrobiolTropDis-8-3-255-2591
Article history: Introduction: Methicillin resistant Staphylococcus aureus is the common pathogen worldwide. It requires
Received 18-07-2022 prolonged therapy to eradicate MRSA from a patient.
Accepted 25-07-2022 Aim: This study was undertaken to determine the changing trend of antimicrobial resistance in MRSA
Available online 06-09-2022 over six years in a tertiary care center.
Materials and Methods: This was a retrospective observational study done at the tertiary care teaching
hospital. The antibiotic sensitivity pattern of the MRSA isolated from various clinical samples from January
Keywords:
2013–December 2018 was studied. The data collected was entered in the Microsoft excel 2007, coded and
Methicillin resistant Staphylococcus
were analyzed by frequency and percentage.
aureus (MRSA) Results: During the study period from January 2013 to December 2018, 1006 (27.42%) patients had MRSA
antimicrobial resistance (AMR) out of 3668 patients diagnosed with Staphylococcus aureus infection. Almost equal gender distribution
Trend
was observed with males (52.78%), geriatric patients, i.e., ≥61 years constituted for around 32% infected
Skin & soft tissue infection (SSTI)
patients. The samples that were received during this period included pus (64.59%), blood (26.23%), urine
(5.53%) and sputum (3.65%). Other anti-MRSA drugs had changing resistance rate on year to year basis.
Conclusion: Continuous monitoring of antibiotic sensitivity and rationalizing the use of antibiotics remain
an important and effective strategy to minimize the emergence of multi-drug resistant MRSA strains.
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons
Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon
the work non-commercially, as long as appropriate credit is given and the new creations are licensed under
the identical terms.
For reprints contact: [email protected]
https://doi.org/10.18231/j.ijmmtd.2022.050
2581-4753/© 2022 Innovative Publication, All rights reserved. 255
256 Anjan et al. / IP International Journal of Medical Microbiology and Tropical Diseases 2022;8(3):255–259
one of the most common causes of hospital-acquired the Microsoft excel 2007, coded and were analyzed by
infection all over the world. Prolonged duration of hospital frequency and percentage.
stay, intravenous drug abuse and irrational use or over-
prescription of antibiotics are important risk factors for 4. Results
MRSA acquisition. These factors along with the diversity in
mecA gene (responsible for resistant mechanisms of MRSA During the study period from January 2013 to December
isolates) pose a major challenge to prevent the spread of 2018, a total of 3668 patients were registered in the
disease in both community and hospitals. 4 hospital with Staphylococcus aureus infection. Of these,
Despite extensive infection control efforts, methicillin 1006 (27.42%) individuals were found to have MRSA
resistance among isolates of S. aureus has steadily increased infection. Among the patients infected with MRSA, 52.78%
around the world and in India. The major reservoirs of were male patients and 47.21% were female patients
Staphylococcus in hospitals are colonized/ infected in- showing a slightly higher incidence of the infection in
patients and colonized hospital workers. Transient hand males than females (Table 1). The geriatric patients, i.e.,
carriage of the organism by healthcare workers account ≥61 years constituted for around 32% infected patients
for the major factor for patient to patient transmission. and the least was noticed among individuals <18 years,
Constant monitoring of these strains is essential in order i.e., 9%. The samples that were received during this period
to control their spread in the hospital setting and spread to included pus (64.59%), blood (26.23%), urine (5.53%)
the community. It is very essential to know the prevalence and sputum (3.65%). The ward-wise distribution of the
of MRSA in any location, because of the public health positive samples showed considerable variation, the highest
importance and the threat posed by MRSA infection. 5 being OP (65.6%), then IP (26.93%) and finally from the
In North India study, out of 250 Staphylococcus aureus ICU (7.45%). Out of the 75 samples collected from ICU,
isolated, 115 (46%) were MRSA isolated. 6 Similar high rate 41(54.67%) were from MICU. Maximum isolation was
of prevalence is been noted in other parts of the country. 7 obtained during April-June (29.12%) and the least during
Even though the drugs for the treatment of these October-December (19.58%). Throughout the period of
multidrug resistant pathogens are available, they are costly study there was a steady rise in the MRSA from 8.77%
and toxic. So, to combat this drug resistant pathogen, close in 2013 to 45.44% in 2018 (Figure 1). Among the MRSA
monitoring of the resistance pattern of MRSA is essential. isolates, there was a steady rise in resistance to Clindamycin
Therefore, this study is undertaken to observe any change in and Erythromycin (Fig 2).
the sensitivity pattern of MRSA isolated from patients in a
tertiary care hospital over a period of six years.
Fig. 2: Showing trend of resistance rate of various drugs tested against MRSA during the study period.
Table 1: Demographic details of the sample analysed during the study period 2013-18.
2013 2014 2015 2016 2017 2018 %
Male 20(44.44) 34(45.94) 91(54.81) 99(61.49) 106(51.45) 181(51.12) 52.78
Gender
Female 25(55.55) 40(54.05) 75(45.18) 62(38.50) 100(48.54) 173(48.87) 47.21
OP 10(22.22) 32(43.24) 103(62.04) 110(68.32) 142(69.41) 263(74.29) 65.6
Ward IP 27(60.00) 36(48.64) 55(33.13) 41(25.46) 43(20.87) 69(19.49) 26.93
ICU 7(15.55) 6(8.10) 8(4.81) 10(6.21) 21(10.19) 23(6.49) 7.45
Blood 7(15.55) 18(24.32) 35(21.08) 40(24.84) 51(24.75) 101(28.53) 25.05
Pus/Wound 36(80.00) 53(71.62) 110(66.26) 113(70.18) 155(75.24) 243(68.64) 70.57
Samples
swab
Urine 1(2.22) 0(0) 11(6.62) 6(3.72) 0(0) 6(1.69) 2.38
Sputum 1(2.22) 3(4.05) 10(6.02) 2(1.24) 0(0) 4(1.12) 1.98
<18 4(8.88) 9(12.16) 16(9.63) 11(6.83) 21(10.19) 34(9.60) 9.44
18-30 9(20.00) 12(16.21) 16(9.63) 11(6.83) 28(13.59) 35(9.88) 11.03
31-45 2(4.44) 9(12.16) 22(13.25) 29(18.01) 30(14.56) 58(16.38) 14.91
Age ( yrs)
46-60 21(46.66) 22(29.72) 50(30.12) 57(35.40) 73(35.43) 99(27.96) 32
61-75 6(13.33) 16(21.62) 51(30.72) 42(26.08) 40(19.41) 90(25.42) 24.35
>75 3(6.66) 6(8.10) 11(6.62) 11(6.83) 14(6.79) 38(10.73) 8.25
Jan-Mar 7(15.55) 15(20.27) 23(13.85) 57(35.40) 54(26.21) 122(34.46) 27.63
Apr-Jun 10(22.22) 27(36.48) 52(31.32) 57(35.40) 62(30.09) 85(24.01) 29.12
Months
July-Sept 8(17.77) 16(21.62) 47(28.31) 47(29.19) 49(23.78) 71(20.05) 23.66
Oct-Dec 20(44.44) 16(21.62) 44(26.50) 0(0) 41(19.90) 76(21.46) 19.58
258 Anjan et al. / IP International Journal of Medical Microbiology and Tropical Diseases 2022;8(3):255–259
showed decreasing trend in its resistance pattern (Figure 2). emergence of multi-drug resistant MRSA strains. However,
No MRSA strains were found resistant to Vancomycin, we found no strains resistant to Vancomycin, Linezolid and
Teicoplanin and Linezolid during the study. Teicoplanin, indicating need for prudent use of these drugs
for treatment of MRSA related infections.
5. Discussion
7. Conclusion
The six year long study shows an overall MRSA incidence
rate of 27.43% in the hospital. The findings are comparable In the present study, it was observed that there was a steady
with most of the reports where it ranged between 20% to rise in the MRSA from 8.77% in 2013 to 45.44% in 2018.
32.8%. 9,10 In the present study, MRSA was mostly isolated Among the patients infected with MRSA, slightly higher
from pus and wound swabs whereas a high prevalence of incidence was noted in males and in the geriatric age group.
MRSA (35% in ward and 43% in ICU) was observed from Most of the MRSA were isolated from pus and exudates
blood culture specimens in a study in Delhi. 11 In studies (70.57%) from skin and soft tissue infections. Majority
conducted in various hospitals in Nepal, MRSA were mostly of patients samples who were infected with MRSA were
isolated from pus specimen compared to other clinical from OP (65.6%) compared to IP and ICU admissions.
specimens. 12,13 In this study, MRSA isolation rates from The drug resistance pattern varied for different antibiotics,
ICU (7.45%) and wards (34.38%) were lower than that seen with an overall decreasing trend in the antibiotic resistance
among outpatients (65.6%) which is contrary to another pattern “between” 2013-18. However, there were rise and
study conducted in India which showed higher MRSA fall of resistance rate for individual antibiotics annually.
isolation from IPDs (69.82%) than from OPDs (30.18%). 14 But, Erythromycin and Clindamycin showed increasing
We found the occurrence of MRSA to be higher in resistance to MRSA.
the geriatric age group i.e., ≥61 years constituted for
around 32% infected patients and the least was noticed 8. Conflict of Interest
among individuals <18 years, i.e., only 9%.In a similar
study, patients between 0-10 age group showed the None.
maximum MRSA (31.5%), followed by age group 11-
20 (26.3%). 15 The study showed slightly higher incidence 9. Source of Funding
of MRSA infection in males than in females. A similar Mr. Nayan Anjan received ICMR STS 2019 fellowship for
study conducted in another Indian hospital had slightly the project.
higher incidence of female patients than males. 14 We have
seen downward trend in resistance among most of the References
antimicrobials except for Erythromycin and Clindamycin.
1. Lowy FD. Staphylococcus aureus infections. N Engl J Med.
We observed similar increase in resistance to Erythromycin 1998;339(8):520–32.
and Clindamycin in MRSA in blood samples from 2. Petti CA, Fowler VG. Staphylococcus aureus bacteremia and
2012-16. 16 A seven year retrospective study showed a endocarditis. Cardiol Clin. 2003;21(2):219–33. doi:10.1016/s0733-
reduction in the percentage of resistance in Staphylococcus 8651(03)00030-4.
3. Tognetti L, Martinelli C, Berti S, Hercogova J, Lotti T, Leoncini
aureus for the antibiotics Gentamicin and Cotrimoxazole F, et al. Bacterial skin and soft tissue infections: review of
but increase in the drug resistance was observed for the epidemiology, microbiology, aetiopathogenesis and treatment: a
antibiotics Amikacin, Ciprofloxacin, Erythromycin and collaboration between dermatologists and infectivologists. J Eur Acad
Clindamycin, 17 which is contrary to our study. This shows Dermatol Venereol. 2012;26(8):931–41.
4. Oliveria DC. Secrets of success of a human pathogen: molecular
that resistance pattern can vary among different population evolution of pandemic clones of methicillin-resistant Staphylococcus
in different area and warrants the regular monitoring of the aureus. Lancet Infect Dis. 2002;2(3):180–9.
changing trends of the resistance pattern among MRSA. 5. Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, Cornaglia
G, et al. A European survey of antibiotic management of methicillin-
resistant Staphylococcus aureus infection: current clinical opinion and
6. Summary practice. Clin Microbiol Infect. 2010;16(1):3–30.
6. Arora S, Devi P, Arora U, Devi B. Prevalence of methicillin-resistant
The study recommends continuous monitoring of antibiotic Staphylococcus aureus in a tertiary care hospital in northern india. J
sensitivity of MRSA, since the drug resistance pattern Lab Physicians. 2010;2(2):78–81.
varies for different antibiotics during the study period. 7. Angel MR, Balaji V, Prakash J, Brahmadathan KN, Mathews MS.
Even though, most of the antibiotics, except Erythromycin Prevalence of inducible clindamycin resistance in gram positive
organisms in a tertiary care centre. Indian J Med Microbiol.
and Clindamycin, showed an overall decreasing trend 2008;46(9):2842–7.
in the antibiotic resistance pattern “between” 2013-18, 8. Clinical and Laboratory Standards Institute. Performance Standards
there were rise and fall of resistance rate in individual for Antimicrobial Susceptibility Testing; Twenty-Fifth Information
Supplement. CLSI documentM100-S25. Clinicaland Laboratory
antibiotics yearly. Therefore, continuous monitoring of
Standards Institute, 950 West Valley Road, Suite 2500, Wayne,
antibiotic sensitivity and rationalizing the use of antibiotics Pennsylvannia 19087 USA; 2015.
remain an important and effective strategy to minimize the
Anjan et al. / IP International Journal of Medical Microbiology and Tropical Diseases 2022;8(3):255–259 259
9. Shankar CU, Harish BN, Kumar PU, Navaneeth BV. Prevalence 17. Jakribettu RP, Nawaz S, D’souza O, Pinto VS, D’souza B, Tellis LA,
of methicillin resistant Staphylococcus aureus in JIPMER hospital. et al. Study of antibiotic resistance pattern in Staphylococcus aureus
Indian J Med. 1997;15:137–8. in skin and soft tissue infections: A seven year analysis. Int J Appl
10. Mehta AP, Rodrigue C, Seth K, Jani S, Hakimiyar A, Fazalbhoy N. Res. 2017;3(9):302–4.
Control of methicillin resistant Staphylococcus aureus in a tertiary
care centre: A five year study. Indian J Med Microbiol. 1998;16:31–4.
11. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prasad KJ, et al. Author biography
Surveillance of multidrug resistant organisms in tertiary care hospital
in Delhi, India. J Assoc Physicians India. 2010;58:32–6.
12. Sanjana RK, Singh R, Chaudhary N. Prevalence and antimicrobial Nayan Anjan, Student
susceptibility pattern of MRSA in CMS Teaching Hospital. J Coll
Med Sci- Nepal. 2010;6(1):1–6. Vidya Rao S, Quality Control Manager
13. Rai SK, Tuladhar NR, Shrestha HG. Methicillin resistant S. aureus
in a tertiary medical care centre Nepal. Indian J Med Microbiol.
1990;8:108–9. Kanniyan Binub, Associate Professor
14. Suryadevara VD, Basavaraju A, Vasireddy K. Prevalence of MRSA
among clinical isolates and their antibiogram in a tertiary care hospital. Preethy Edavaloth, Resident
J Evolution Med Dent Sci. 2017;6(21):1667–9.
15. Bhatt C, Karki B, Baral B, Gautam S, Shah A, Chaudhary A, Ramakrishna Pai Jakribettu, Professor & Head https://orcid.org/0000-
et al. Antibiotic susceptibility pattern of staphylococcus aureus and 0001-6403-3344
methicillin-resistant staphylococcus aureus in a tertiary care hospital.
J Pathol Nepal. 2014;4(7):548–51.
16. Ahmed SM, Jakribettu RP, Rajeevan S, George A, Mariyam MA,
Rao SV, et al. Five‑year trend of bacterial isolates and their Cite this article: Anjan N, Vidya Rao S, Binub K, Edavaloth P,
antibiotic resistance from automated BACTEC blood culture system Jakribettu RP. Study of antibiotic resistance pattern in
from a rural medical college hospital in North Kerala. J Acad Clin Methicillin-resistant Staphylococcus aureus: A six year analysis. IP Int
Microbiol. 2019;21(1):10–5. J Med Microbiol Trop Dis 2022;8(3):255-259.